anmeldenEQS-AFR: Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
Werte in diesem Artikel
|
EQS Preliminary announcement financial reports: Heidelberg Pharma AG
/ Preliminary announcement on the disclosure of financial statements
Werbung
Heidelberg Pharma AG hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report Language: German Date of disclosure: March 21, 2025 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: March 21, 2025 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports Report Type: Annual financial report of the group Language: German Date of disclosure: March 21, 2025 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: March 21, 2025 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports Report Type: Financial report of the group (half-year/Q2) Language: German Date of disclosure: July 10, 2025 Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte Language: English Date of disclosure: July 10, 2025 Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports
23.01.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Heidelberg Pharma AG |
| Gregor-Mendel-Str. 22 | |
| 68526 Ladenburg | |
| Germany | |
| Internet: | www.heidelberg-pharma.com |
| End of News | EQS News Service |
|
|
2073631 23.01.2025 CET/CEST
Ausgewählte Hebelprodukte auf Heidelberg Pharma
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Heidelberg Pharma
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Heidelberg Pharma Aktie News
Heidelberg Pharma Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Heidelberg Pharma nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.02.13 | WILEX kaufen | equinet | |
| 23.01.13 | WILEX kaufen | equinet AG | |
| 19.06.12 | WILEX buy | WestLB AG | |
| 19.10.11 | WILEX buy | WestLB AG | |
| 17.06.10 | WILEX Stoppkurs 6,90 EUR | Focus Money |